(Q36099453)

English

A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

cancer-associated fibroblast

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Corrigendum: A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

1 reference

10.1038/SREP46841

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/SREP46841

Author Correction: A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

0 references

author name string

Meihua Chen

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rong Xiang

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yuan Wen

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Guangchao Xu

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Chunting Wang

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Shuntao Luo

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Tao Yin

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Xiawei Wei

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Bin Shao

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Ning Liu

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Fuchun Guo

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Meng Li

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Shuang Zhang

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Minmin Li

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Kexing Ren

15

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yongsheng Wang

16

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yuquan Wei

17

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

23 September 2015

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Scientific Reports

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

14421

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Gene therapy with beta-defensin 2 induces antitumor immunity and enhances local antitumor effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Targeting immunosuppression for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Overview of the cancer vaccine field: are we moving forward?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer immunotherapy comes of age

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer associated fibroblasts: the dark side of the coin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Whole tumor antigen vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Whole-cell vaccines: A failure or a success waiting to happen?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer associated fibroblasts in cancer pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer-associated fibroblasts and tumor growth--bystanders turning into key players

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Regulation of inflammation- and angiogenesis-related gene expression in breast cancer cells and co-cultured macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer-related inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Seprase: an overview of an important matrix serine protease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Overview of tumor cell-based vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Stromal fibroblasts in cancer: a novel tumor-promoting cell type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 October 2017

Cancer. Awakening immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 July 2018

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

2 July 2018

Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

23 September 2018

[Interaction of cancer-associated fibroblasts and tumor cells in carcinogenesis].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

23 September 2018

A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

23 September 2018

Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

23 September 2018

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

23 September 2018

Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 163

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585784

23 September 2018

Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/26394925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/26394925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steps towards a prophylactic breast cancer vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26394925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/26394925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of fibroblast activation protein in patients with colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26394925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/26394925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SREP14421

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36099453&oldid=2198198159"